Cargando…
Visible-Light-Controlled Histone Deacetylase Inhibitors for Targeted Cancer Therapy
[Image: see text] The lack of selectivity of anticancer drugs limits current chemotherapy. Light-activatable drugs, whose activity can be precisely controlled with external light, could provide a more localized action of the drugs in the tumor, thus decreasing side effects and increasing efficacy. H...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2023
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949698/ https://www.ncbi.nlm.nih.gov/pubmed/36654474 http://dx.doi.org/10.1021/acs.jmedchem.2c01713 |